Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Francesca Bruce

Francesca Bruce has been writing news and analysis about all things affecting the pharmaceutical industry since 2008. She has paid special attention to policy and regulatory developments but particularly likes to write about market access and how medicines may  - or may not  -  make it to patients. She generally writes about Europe, but really enjoys uncovering news from further corners of the globe, especially Latin America and the Middle East.

Latest From Francesca Bruce

Is International Reference Pricing Still Relevant?

International reference pricing is becoming more irrelevant as increasing emphasis is placed on other cost-containment measures.

International Market Access

Regulators Call for More Harmonization On Ultra-Rare ATMPs

Early discussions between companies and multiple regulators could drive greater alignment among jurisdictions.

Europe US States

Can The UK Remain A First Launch Market?

More pollical support from the National Health Service and health ministers is needed to ensure the UK’s future as a desirable launch market.

Europe United Kingdom

Gilead’s Trodelvy To Test UK Innovative Drug Pathway

The cancer drug is also to undergo an accelerated assessment by the European Medicines Agency.

Europe United Kingdom

EU Council Agrees Compromise Position On Joint Clinical Assessments

The Alliance For Regenerative Medicines is calling for advanced therapies to be given greater priority where joint clinical assessments are concerned.

Europe Health Technology Assessment

UK Clinical Research Vision To Drive Novel Trial Design

A pilot conducted by the UK medicines agency to improve patient involvement in research will support newly announced plans to improve clinical research.

Europe United Kingdom
See All
UsernamePublicRestriction

Register